Bal Pharma Shareholding Pattern & Promoter Holding

Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026

As of Sep 2026, promoters hold 50.87% of Bal Pharma, FIIs hold 0.28%, DIIs hold — and the public holds 48.87%. Promoter holding was unchanged from Jun 2026.

Get an alert when Bal Pharma reports results or its shareholding changes. Free account.

Promoters

50.87%

unchanged QoQ

FIIs

0.28%

+0.13 pp QoQ

DIIs

—

— QoQ

Public

48.87%

−0.12 pp QoQ

Bal Pharma shareholding, quarter by quarter

QuarterPromotersFIIsPublicShareholders
Sep 202650.87%0.28%48.87%15,241
Jun 202650.87%0.15%48.99%14,974
Mar 202650.87%0.14%49.01%15,214
Dec 202550.87%0.14%49.01%15,520
Sep 202550.87%0.23%48.91%15,774
Jun 202550.87%0.15%48.99%15,826
Mar 202550.87%0.14%49.01%15,723
Dec 202450.87%0.14%49.00%15,667
Sep 202450.87%0.13%49.01%16,007
Jun 202451.24%0.13%48.63%15,014
Mar 202451.24%0.13%48.64%14,772
Dec 202351.24%0.13%48.64%15,060

Promoters · FIIs (foreign institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.

Value of the promoter stake

At a market capitalisation of ₹143 cr, the promoter group's 50.87% stake is worth ₹73 cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.

Promoter holding in Pharmaceuticals & Biotechnology peers

Bal Pharma shareholding: common questions

What is the promoter holding in Bal Pharma?

Promoters hold 50.87% of Bal Pharma as of Sep 2026. Their stake was unchanged from Jun 2026.

How much do FIIs hold in Bal Pharma?

Foreign institutional investors (FIIs) held 0.28% of Bal Pharma in Sep 2026, +0.13 pp versus Jun 2026.

Is the promoter holding in Bal Pharma pledged?

The latest disclosed shareholding pattern shows no pledged promoter shares in Bal Pharma.

How has Bal Pharma's promoter holding changed in the last year?

Promoter holding moved from 50.87% in Sep 2025 to 50.87% in Sep 2026 (unchanged).

How many shareholders does Bal Pharma have?

Bal Pharma had 15,241 shareholders in Sep 2026, compared with 14,974 in Jun 2026.